Dermira eyes $80M IPO; Merck: Patients are open to sharing their genomes;

@FierceBiotech: FierceBiotech's 2014 Fierce 15. Congrats to those who made the list! | Follow @FierceBiotech

@JohnCFierce: Always fun to watch the web traffic explode when we blast the Fierce 15. | Follow @JohnCFierce

@DamianFierce: Merck KGaA gets around to that big deal it's been talking up: $SIAL for $17B. More | Follow @DamianFierce

> Dermira is looking to pull off an $80 million IPO, seeking cash to bankroll its pipeline of treatments for psoriasis, acne and excessive sweating. News

> San Diego's Lpath ($LPTN) signed a deal to raise $12.5 million to advance its platform of lipid-targeted antibodies. More

> A survey conducted by Merck ($MRK) suggests that patients are willing to hand over their genomic information--at a price--to help drugmakers craft new therapies. Story

Medical Device News

@FierceMedDev: Zimmer partners with MiMedx to sell bioimplants to promote healing. Article | Follow @FierceMedDev

@MichaelGFierce: Vaxxas' nanopatch garners WHO support in search of #polio vax application. Story | Follow @MichaelGFierce

@VarunSaxena2: Court ruling against FDA should enable more combination products to be classified as devices. Article | Follow @VarunSaxena2

@EmilyWFierce: British startup launches crowdfunding effort for 3-D printed orthotic devices. More | Follow @EmilyWFierce

> University of Louisville working on 'bioficial heart' using 3-D printing. Story

> Physicians defend power morcellator devices amid industry fallout. Article

Pharma News

@FiercePharma: Eylea gets yet another approval, this one in Japan. More | Follow @FiercePharma

@EricPFierce: Potentially bad news for Amphastar and its $155.7M deal if Sanofi makes insulin for Mannkind. Article | Follow @EricPFierce

@CarlyHFierce:  Inversion pushback won't scare Horizon Pharma out of Ireland move. Story | Follow @CarlyHFierce

> Auxilium says Endo offer not enough to break off with QLT. News

> Merck KGaA declares $17B Sigma purchase 'quantum leap' as drug biz struggles. Article

> Eylea gets yet another approval, this one in Japan. More

CRO News

> Packaging outfit PCI buys trial supplier Biotec. News

> Survey says: Big CROs are only getting bigger. Report

> CRO FlowMetric gets into diagnostics with new spinout. Story

> TransCelerate dishes on risk-based monitoring. Item

> Covance borrows Fresenius' data to improve kidney treatments. Article

Biotech IT News

> Vivametrica makes pitch for mHealth data aggregation and analysis market. Report

> Stanford and Duke to trial Apple's HealthKit for remote data collection. More

> Merck survey finds patients willing to share NGS data with pharma companies. Story

> BBK bags $3M to expand its eClinical suite. Item

> AstraZeneca opens Indian IT center as 13-year outsourcing experiment nears end. Article

Animal Health News

> Work on the National Bio and Agro-Defense Facility continues. More

> EU gives nod to Merck's poultry vaccine to fight infectious bronchitis. Report

> Phibro reports strong sales in animal growth and nutrition sectors. Article

> Will Zoetis stand alone when Big Pharma's music stops? More

> Packaging outfit PCI buys trial supplier Biotec. Story

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.